Related Experiment Video
Updated: Aug 17, 2026
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
[Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital--4th
S Alfandari1, O Leroy, S de Botton
1Service de réanimation et maladies infectieuses, centre hospitalier Dron, 59208 Tourcoing, France. alfandari@nordnet.fr
Abstract:
Invasive aspergillosis is a severe complication in immunocompromised patients. The arrival of new antifungal agents motivated the redaction of guidelines, regularly updated, by a Lille University hospital multidisciplinary task force. These guidelines assess diagnostic and therapeutic issues. The main recommended diagnosis tool is the chest CT scan, ordered at the smallest suspicion and, also, measure of the blood and broncho alveolar lavage fluid galactomannan. Treatment guidelines assess prophylaxis, empirical and documented therapy. Primary prophylaxis is warranted in only two cases, pulmonary graft or stem cell transplant in patients with chronic GVH and receiving corticosteroids. Empirical therapy should use one of the available amphotericin B formulations, chosen according to the patient history. Caspofungin is another choice. Documented therapy, depending on presentation, can be a single drug or a combination. First line therapy for single drug is i.v. voriconazole. Lipid formulations of amphotericin B are another choice. A combination therapy can be used as a first line treatment, for multiple lesions, or as salvage therapy. It must include caspofungin, associated with liposomal amphotericin B or voriconazole. A tight cooperation with thoracic surgeons is recommended.
Insights
Updated guidelines for invasive aspergillosis in immunocompromised patients recommend chest CT scans and galactomannan testing for diagnosis. Treatment strategies include prophylaxis, empirical, and documented therapies with new antifungal agents.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Context:
- Invasive aspergillosis poses a significant threat to immunocompromised individuals.
- Advancements in antifungal therapies necessitate updated clinical management strategies.
- Lille University hospital has established a multidisciplinary task force for guideline development.
Purpose:
- To provide updated diagnostic and therapeutic guidelines for invasive aspergillosis.
- To integrate new antifungal agents into clinical practice recommendations.
- To offer a comprehensive approach to managing this severe fungal infection.
Summary:
- Diagnostic recommendations emphasize chest CT scans and galactomannan testing in blood and bronchoalveolar lavage fluid.
- Prophylaxis is restricted to specific high-risk scenarios like stem cell transplant recipients with chronic GVHD on corticosteroids.
- Empirical therapy options include amphotericin B formulations or caspofungin, while documented therapy may involve voriconazole or combination regimens.
Impact:
- These guidelines aim to improve patient outcomes by standardizing the diagnosis and treatment of invasive aspergillosis.
- The recommendations facilitate the optimal use of novel antifungal agents.
- Enhanced collaboration with thoracic surgeons is advised for complex cases.
Related Concept Videos
01:27Cryptococcal Meningitis
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:30Asthma-IV: Nursing Management
First, in...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.